NPS PHARMACEUTICALS INC: current_assets
| Value | {"amount": 156369000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-03-31) |
| Status | current |
| Entity | NPS PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:56:45.347475+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/72f78cfe-a468-4ad5-b700-244d1ff0f799
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001136261-13-000211 · Open the official SEC filing →Retrieved: 2026-08-19T08:56:45.347475+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000890465/current-assets/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/72f78cfe-a468-4ad5-b700-244d1ff0f799
History
- no predecessors — first report